SCHEMBL2972168

SCHEMBL2972168

Fc1ccc(Cl)cc1.[Zn]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL35226 0.96 — —
SCHEMBL7024646 0.96 — —
SCHEMBL5776485 0.96 — —
Fluoride SCHEMBL21986315 0.93 LMNA (0.57) —
SCHEMBL3821175 0.93 — —
SCHEMBL7929388 0.87 NPC1 (0.60) —
Hydrazine SCHEMBL17259295 0.87 LMNA (0.50) —
SCHEMBL21617684 0.87 LMNA (0.50) —
SCHEMBL28682658 0.84 LMNA (0.47) —
Boric Acid SCHEMBL2461186 0.84 ORAI1 (0.50) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107488190-B Ezetimibe intermediate and preparation method thereof 山东新时代药业有限公司 2021-07-02 — — CN disclosed
CN-107488138-B Ezetimibe synthesis method 山东新时代药业有限公司 2021-05-04 — — CN disclosed
CN-107488165-B Ezetimibe intermediate compound 山东新时代药业有限公司 2021-05-04 — — CN disclosed
CN-107488173-B Ezetimibe intermediate and synthetic method thereof 山东新时代药业有限公司 2021-05-04 — — CN disclosed
CN-112441959-A Ezetimibe raw material medicine synthesis process 石家庄市华新药业有限责任公司 2021-03-05 — — CN disclosed
CN-107488164-B Ezetimibe intermediate compound 山东新时代药业有限公司 2020-08-14 — — CN disclosed
CN-104892537-B The synthetic method of Ezetimibe intermediate and Ezetimibe 江西施美药业股份有限公司 2018-07-17 — — CN disclosed
CN-107488190-A A kind of Ezetimibe intermediate and preparation method thereof 山东新时代药业有限公司 2017-12-19 — — CN disclosed
CN-107488138-A A kind of Ezetimibe synthetic method 山东新时代药业有限公司 2017-12-19 — — CN disclosed
CN-107488173-A A kind of Ezetimibe intermediate and its synthetic method 山东新时代药业有限公司 2017-12-19 — — CN disclosed
CN-1527707-A The use of substituted azetidinone compounds for the treatment of sitosterolemia ���鹫˾ 2004-09-08 — — CN disclosed
WO-2004050624-A1 SUBSTITUTED 1H-PYRIDINE-2-ONE DERIVATIVES C & C RESEARCH LABORATORIES (KR) 2004-06-17 — — WO disclosed
EP-0673942-B1 Silacyclohexanone compounds as intermediates for the preparation of silacyclohexane-type liquid cristal compounds SHINETSU CHEMICAL CO (JP) 2000-11-08 — — EP disclosed
CN-1050830-C Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents SCHERING CORP (US) 2000-03-29 — — CN disclosed
EP-0670322-B1 A silacyclohexane compound, a method of preparing it and a liquid crystal composition containing it SHINETSU CHEMICAL CO (JP) 2000-01-19 — — EP disclosed
US-5641431-A Silacyclohexanone compound and a method of preparing a silacyclohexane-type liquid crystal composition containing it SHIN-ETSU CHEMICAL CO., LTD. (JP) 1997-06-24 — — US disclosed
US-5582764-A Silacyclohexane compound, a method of preparing it and a liquid crystal composition containing it SHIN-ETSU CHEMICAL CO., LTD. (JP) 1996-12-10 — — US disclosed
CN-1131416-A Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents SCHERING CORP (US) 1996-09-18 — — CN disclosed
EP-0673942-A1 Silacyclohexanone compounds as intermediates for the preparation of silacyclohexane-type liquid cristal compounds Shin-Etsu Chemical Co., Ltd. (JP) 1995-09-27 — — EP disclosed
EP-0670322-A1 A silacyclohexane compound, a method of preparing it and a liquid crystal composition containing it Shin-Etsu Chemical Co., Ltd. (JP) 1995-09-06 — — EP disclosed
Send feedback